RE:Envelope math. bigask2013 wrote: At $1.90 s/p and after this deal, PHM would be trading at roughly 12.5 times Ebitda (30M annually), considering they have 50 million left in the bank which represents approx. 15% of the share price and total O/S shares after the deal/options of 272,670,000 (of which approx. 15% would be attributed to cash). Ebitda per remaining shares is approx 12.6 cents per share. As far as dividends. That scenario was given up on, long ago. As far as Nastaq listing, they would not qualify until about a year from now. The numbers aren't there yet.
RE: O/S, a little scary considering in comparison VRX has only 341 m O/S and a market cap of 97 B. Apples and oranges maybe, but the roll up model is the same.